Friday, June 12, 2009

Evidence for...Pycnogenol for asthma

Pycnogenol as an adjunct in the management of childhood asthma.
Lau BH et al.
J Asthma. 2004;41:825-32.
Compared with placebo, three months' treatment with Pycnogenol (a proprietary mixture of water-soluble bioflavonoids extracted from French maritime pine) in children and teenagers (aged 6-18 years) with mild-to-moderate asthma resulted in significantly greater improvement in pulmonary functions and asthma symptoms. The Pycnogenol group was also able to reduce or discontinue their use of rescue inhalers more often than the placebo group.


Pycnogenol in the management of asthma.
Hosseini S et al.
J Med Food. 2001;4:201-9.
Patients with varying asthma severity treated with Pycnogenol 1 mg/lb/day (maximum 200 mg/day) for 4 weeks experienced significant reductions in serum leukotrienes (naturally produced substances that promote asthma symptoms).

No comments:

Post a Comment